Key Corporate Account Director - Northeast

About Pharma Essentia

It’s not often you get the chance to make a real impact on the lives of others, while expanding your own possibilities. You’ll find that rare opportunity n us, and let’s transform lives, together. Pharma Essentia Corporation is a rapidly growing biopharmaceutical innovator. We are leveraging deep expertise and proven scientific principles to deliver effective new biologics for challenging diseases in the areas of hematology and oncology, with one product approved and a diversifying pipeline.

We believe in the potential to improve both health and quality of life for patients with limited options today through the combination of rigorous research and innovative thinking. Founded in 2003 by a team of Taiwanese‑American executives and renowned scientists from U.S. biotechnology and pharmaceutical companies, today we are listed on the Taiwan Stock Exchange (TWSE: 6446) and are expanding our global presence with operations in the U.S., Japan, Singapore, South Korea, and China, along with a world‑class biologics production facility in Taichung.

The Key Corporate Account Director (KCAD) is responsible for strategic customer engagement and access execution across an assigned geographic territory that includes large community oncology clinics, oncology provider networks, specialty GPO member organizations, and NCI‑designated/NCCN member academic cancer centers and academic medical centers. The KCAD operates across both GPO‑driven network environments and institutional academic health systems, partnering with complex, multi‑level stakeholders to develop and execute account‑specific access strategies, implement institutional access plans, and proactively navigate formulary, systems, and process challenges that impact product availability.

A core focus of the role is building deep account expertise and durable stakeholder relationships to ensure Pharma Essentia products are accessible within health system and/or oncology provider networks and clinics; accurately represented in clinical and administrative systems; appropriately embedded within the clinical workflows physicians use to treat patients. The KCAD does not generate HCP prescribing demand. Instead, the role ensures the organizational and institutional conditions for demand are in place, enabling seamless operational or access processes for all customer segments.

This is achieved through targeted engagement with healthcare decision makers who influence contracting, formularies, pathways, and ordering and dispensing infrastructure. The KCAD’s responsibilities span core access pillars: GPO contracting and pull‑through execution across community oncology and network‑based accounts; optimize access through Oncology Optimized Limited Distribution model; influence of clinical systems and ordering infrastructure, including formularies, pathways, EMR ordering, and decision‑support tools to create organizational demand;

strategic stakeholder engagement and institutional communications across medical, pharmacy, population health, and administrative leadership. Market access insights generated through customer engagement, data analysis, and cross‑functional collaboration with Sales, Marketing, Medical Affairs, and Market Access partners are central to driving effective account planning, informing enterprise strategy, and aligning execution across the field organization. The KCAD reports to the Senior Director, Corporate Accounts & GPO Strategy.

• Support launch planning and ongoing access strategy for current and future products by developing and executing account‑level access plans across community oncology networks, GPO member accounts, and NCI‑designated/NCCN academic cancer centers within the assigned territory.
• Inform and execute GPO contract strategy within assigned accounts, including contract negotiation, launch initiatives, and pull‑through activity to ensure contracted accounts are actively utilizing and ordering PEC products through the appropriate channel.
• Lead engagement with population health and account decision makers—including medical, quality, pharmacy, specialty pharmacy, clinical,…